June 2007 Oncology News International
Focus on Hematology
Meta-Analysis Shows Rituximab-Chemo Increases Overall Survival in Indolent/Mantle Cell Lymphoma
Velcade/Doxil Approved for Relapsed or Refractory Multiple Myeloma Pts
Focus on Breast Cancer
Novel PET Tracer Detects Breast Tumors and Mets
Vitamin E-Based Paclitaxel May Be Less Neurotoxic
Removing Stage IV Primary May Cut Mortality
Focus on Lung Cancer
Canfosfamide Boosts Chemotherapy's Benefit in NSCLC
Best Measure of Lung Cancer Screening: Curability or Mortality?
Industry Watch
Enrollment Begins for Phase I Trial of NPI-0052 in Myeloma
PEG-SN38 Shows Anti-Tumor Activity in Resistant Models
Cougar Biotechnology Reports Positive Data on CB7630
Focus on Colon Cancer
Colonoscopy With Polyp Removal Reduces Mortality
Surveillance Colonoscopy Guidelines Not Being Followed
Cancer Care & Economics
Virtual Colonoscopy Gaining New Respect as a Sensitive and Cost-Effective CRC Screening Tool
Medicare Reacts to Recent Scrutiny of ESAs
Value-Based Competition Key to Healthcare Reform
Focus on Oncology Nursing
Gastric Ca Registry IDs Those With CDH1 Mutation
![We must work on clinical predictors based on the disease phenotype, we must work on the physician’s attitude, and [we must work to] stimulate the correct and timely usage of ruxolitinib.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2Fd5a069c33bbfe917bc7c0b1bb13d76c0a815cc44-234x234.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "We must work on clinical predictors based on the disease phenotype, we must work on the physician’s attitude, and [we must work to] stimulate the correct and timely usage of ruxolitinib.")
